New on the blog: Compounded Semaglutide and Tirzepatide vs Brand-Name GLP-1s: What to Know
October 30, 2026 · 0:11
New on the blog Compounded vs brand-name GLP-1s What changed when the shortages ended
Looking for a Primary Care Provider?
Checkups, preventive care and ongoing care for chronic conditions in West Ashley, Charleston. New patients are often able to be scheduled within a week of requesting an appointment. Schedule an appointment today.
Frequently Asked Questions
During the GLP-1 shortages, compounding pharmacies made their own versions of semaglutide and tirzepatide, and many online services still sell them. They are usually cheaper than brand-name Ozempic, Wegovy, Mounjaro or Zepbound.
The FDA declared the tirzepatide and semaglutide shortages resolved in late 2024 and early 2025. Once a shortage ends, the rules that allowed pharmacies to make large batches of copies end too.
Products from unlicensed sellers may contain the wrong amount of drug, or none at all.
More Short Videos
-
New on the blog: Sleep and Mental Health: When Poor Sleep and a Low Mood Go Together
-
New on the blog: Chronic Care Management: Care That Keeps Going Between Visits
-
New on the blog: Sleep Apnea: Signs, Sleep Testing and Treatment
-
New on the blog: Wellbutrin for ADHD: When Bupropion Makes Sense for Adults